Nexalin Technology, Inc. Proceeds from Notes Payable
Nexalin Technology, Inc. (NXL) reported Proceeds from Notes Payable of $200.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-27.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2023-03-27
- Nexalin Technology, Inc. proceeds from notes payable for fiscal 2021 was $200.00K.
| Period end | Proceeds from Notes Payable 12 month |
|---|---|
| 2021-12-31 | $200.00K 10-K · filed 2023-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| EDAP TMS SA (FOCL) | $0.171B | ||
| IRIDEX CORP (IRIX) | United States | $0.011B |